Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.174,01
0,45%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Protalix BioTherapeutics Inc (PLX) Protalix BioTherapeutics Inc (PLX) Notizie

PLX

Protalix BioTherapeutics (PLX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:PLX
DataOraFonteTitoloSimboloCompagnia
02/01/202412:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
26/12/202312:56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
30/11/202310:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
06/11/202313:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
31/10/202321:40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
20/10/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
15/09/202322:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
06/09/202312:50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
11/08/202322:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
07/07/202322:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
29/06/202313:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202322:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202322:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
18/05/202323:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202314:27Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PLXProtalix BioTherapeutics Inc
01/05/202312:48Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202313:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202312:47Edgar (US Regulatory)Annual Report (10-k)AMEX:PLXProtalix BioTherapeutics Inc
03/01/202312:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PLXProtalix BioTherapeutics Inc
14/11/202213:08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PLXProtalix BioTherapeutics Inc
09/09/202223:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PLXProtalix BioTherapeutics Inc
14/07/202222:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PLXProtalix BioTherapeutics Inc
05/07/202222:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PLXProtalix BioTherapeutics Inc
09/06/202220:53Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202212:26Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PLXProtalix BioTherapeutics Inc
20/04/202222:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:PLXProtalix BioTherapeutics Inc
23/10/202023:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PLXProtalix BioTherapeutics Inc
14/08/202023:03Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:PLXProtalix BioTherapeutics Inc
01/06/202023:22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PLXProtalix BioTherapeutics Inc
29/04/202023:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PLXProtalix BioTherapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:PLX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network